Cureus and Cancer Commons Launch Medical Publishing Competition, Draw Attention to Novel Oncology Therapy Responses

Share Article

Results from peer-reviewed studies to be shared with oncologists and patients, encouraging further exploration and evaluation of new, potentially promising cancer therapies.

Determining treatment options can present significant challenges for difficult to treat cancers, and where there are little to no established protocols.

Oncologists and patients often have the difficult task of evaluating multiple cancer treatment options, each with a varying degree of potential outcome and subsequent quality of life. Most of these therapeutic options are “conventional,” having been rigorously explored in studies with large cohorts of patients and extended follow-up. However, determining treatment options can present significant challenges for difficult to treat cancers, and where there are little or no established protocols. This challenge is compounded by the growing knowledge that cancer is thousands of distinct molecular diseases, thus advancing the rapid development of novel treatment options.

In an effort to drive peer-reviewed publication and broader awareness of treating such cases, the Cureus Journal of Medical Science has collaborated with Cancer Commons to highlight potential therapeutic options, and where warranted, inspire continued scientific discovery. Together they have launched a medical publishing competition titled “Exceptional Responders in Oncology.” The program seeks clinician authors to submit patient case reports that document noteworthy experiences when treating challenging cancer cases. The “best paper,” as defined by the competition’s crowdsourced scoring, will be awarded a $3,000 USD prize.

“The competition’s goal is to share clinical experiences with other oncologists and patients who might benefit, so that positive and negative experiences can be quickly considered, scrutinized and further explored,” said John Adler, M.D., founder and CEO of Cureus and professor of neurosurgery and radiation oncology at Stanford University School of Medicine. “This competition also strives to be the proverbial Pulitzer Prize of oncology case reporting, acknowledging the significant achievements and innovative thinking behind the world’s brightest oncology physicians and researchers.”

“Patients are dying today needlessly. Cancer Commons gives oncologists knowledge over and above what they already have – potentially saving the lives of millions of people with the treatment options that are already available,” said William Wong, executive director of Cancer Commons. "By building a commons of both data and a network of people, Cancer Commons helps to tightly integrate cancer research and clinical care around each cancer patient.”

To ensure the competition output reaches a global clinical and patient audience, all case reports will be included in PubMed Central and made available without download access fees commonplace in other peer-reviewed medical journals.

Case report submission is free. Eligible case reports must be submitted for editorial and peer review by November 23, 2015. More information regarding the Exceptional Responders in Oncology publishing competition can be found at http://www.cureus.com/cancercommons.

About Cureus
The Cureus Journal of Medical Science is a no-cost, peer-reviewed online medical publishing platform that leverages a unique crowd-sourced post-publication review process. Relying on the collective intelligence of its clinical community, Cureus enables faster publication, greater access, and ultimately, better research. Visit http://www.cureus.com for more information.

About Cancer Commons
Cancer Commons is a non-profit network of cancer patients, physicians, scientists, volunteers and partners committed to sharing data and knowledge, and using their collective expertise and resources to help save patient lives today and transform cancer care tomorrow. Visit http://www.cancercommons.org for more information.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Adler
Cureus
+1 (650) 714-9565
Email >
@CureusInc
Follow >
Visit website